Varex Imaging Corp (VREX)

NASD · Healthcare · Medical Devices · USA

Varex Imaging Corp is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.

Varex Imaging designs and manufactures X-ray imaging components including tubes, detectors, and linear accelerators for medical diagnostic imaging, security screening, and industrial inspection. The company operates two segments: Medical, serving original equipment manufacturers with components for CT and diagnostic systems, and Industrial, supplying products for cargo screening and nondestructive testing. Operations span North America, Europe, and Asia.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Varex Imaging Corp stock.

Our verdict on VREX

Overvalued: intrinsic value $9.06 per share, market price $18.10, margin of safety -99.8% (as of 2026-11-17).

Its through-the-cycle earnings (8.6% median margin), capitalised at 8.3% with no growth, values the shares at $9.06; the price of $18.10 is 100% above that value.

ETFs with the most weight in VREX

17 more funds hold it; the full list is part of the paid plan.

More on VREX

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than VREX in Medical Devices

37 more in this industry show a wider margin of safety.

Is VREX undervalued or overvalued?

VREX is overvalued (as of the 2026-11-17 close). Its through-the-cycle earnings (8.6% median margin), capitalised at 8.3% with no growth, values the shares at $9.06; the price of $18.10 is 100% above that value.

What is the intrinsic value of VREX?

$9.06 per share (as of the 2026-11-17 close), against a market price of $18.10. That is a margin of safety of -99.8%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.